Considering the elevated level of EGR3 expression at relapse in infant KMT2A-r proB-ALL, we aimed to examine the IGHM, CD79A, BLK, and PTPN6 gene expressions at the time of relapse. The gene discussed is EGR3; the disease is acute lymphoblastic leukemia.